Related Experiment Video
Updated: Oct 26, 2025

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
Microfluidic integrated capacitive biosensor for C-reactive protein label-free and real-time detection
Danyang Liu1, Lin Zhou, Lihong Huang
1Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China. hjmao@mail.sim.ac.cn.
This study presents a novel microfluidic chip with a 3D capacitive biosensor for continuous, on-site biomarker detection. The biosensor demonstrates high sensitivity and specificity for cardiac and periodontitis markers.
Area of Science:
- Biomedical Engineering
- Biosensor Technology
- Microfluidics
Background:
- Capacitive biosensors offer label-free detection capabilities.
- Microfluidic systems enable precise sample handling and integration.
- Three-dimensional (3D) interdigital electrodes enhance sensor performance.
Purpose of the Study:
- To develop and validate a microfluidic chip integrated with a mass-producible 3D capacitive biosensor.
- To enable continuous, on-site detection of cardiac and periodontitis biomarkers.
- To assess the biosensor's specificity, sensitivity, and limit of detection.
Main Methods:
- Fabrication of a microfluidic chip bonded with a 3D interdigital capacitor biosensor.
- Surface functionalization including gold thiol modification, EDC/sulfo-NHS activation, and antibody bioconjugation.
- Characterization using fluorescent methods and X-ray photoelectron spectroscopy (XPS) for antibody immobilization confirmation.
- Label-free detection of C-reactive protein (CRP) using the developed biosensor.
Main Results:
- Successful immobilization of C-reactive protein (CRP) antibodies confirmed by XPS and fluorescence.
- Demonstrated high specificity and sensitivity of the microfluidic-integrated 3D capacitive biosensor.
- Achieved a limit of detection (LOD) of approximately 1 pg mL-1 for label-free CRP detection.
- Continuous on-site monitoring of cardiac and periodontitis biomarkers was successfully performed.
Conclusions:
- The developed microfluidic chip with a 3D capacitive biosensor is a mass-producible platform.
- The biosensor enables high-performance, continuous, on-site detection of relevant biomarkers.
- This technology holds promise for point-of-care diagnostics and health monitoring.
More Related Videos
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
08:22Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018